[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71:209-249.
[2] YOUNG H,KNEPPER B,MOORE E,et al.Surgical site infection after colon surgery:National Healthcare Safety Network risk factors and modeled rates compared with published risk factors and rates[J].J Am Coll Surg,2012,214(5):852-859.
[3] PELUCCHI C,NEGRI E,TALAMINI R,et al.Metabolic syndrome is associated with colorectal cancer in men[J].Eur J Canc,2010,46(10):1866-1872.
[4] SAKLAYEN MG.The global epidemic of the metabolic syndrome[J].Curr Hypertens Rep,2018,20(2):12.
[5] CHEN Y,XU W,ZHANG W,et al.Plasma metabolic fingerprints for large-scale screening and personalized risk stratification of metabolic syndrome[J].Cell Rep Med,2023,4(7):101109.
[6] ECKEL RH,GRUNDY SM,ZIMMET PZ.The metabolic syndrome[J].Lancet,2005,365(9468):1415-1428.
[7] KOCHI T,SHIMIZU M,OHNO T,et al.Enhanced development of azoxymethane-induced colonic preneoplastic lesions in hypertensive rats[J].Int J Mol Sci,2013,14(7):14700-14711.
[8] SHARIQ OA,HANSON KT,MCKENNA NP,et al.Does metabolic syndrome increase the risk of postoperative complications in patients undergoing colorectal cancer surgery[J].Dis Colon Rectum,2019,62(7):849-858.
[9] ZHOU CJ,CHENG YF,XIE LZ,et al.Metabolic syndrome,as defined based on parameters including visceral fat area,predicts complications after surgery for rectal cancer[J].Obes Surg,2020,30(1):319-326.
[10] CRUZ-JENTOFT AJ,LANDI F,SCHNEIDER SM,et al.Prevalence of and interventions for sarcopenia in ageing adults:a systematic review.Report of the International Sarcopenia Initiative (EWGSOP and IWGS)[J].Age Ageing,2014,43(6):748-759.
[11] CHEN LK,LIU LK,WOO J,et al.Sarcopenia in Asia:consensus report of the Asian Working Group for Sarcopenia[J].J Am Med Dir Assoc,2014,15(2):95-101.
[12] 朱大龙.中国2型糖尿病防治指南(2020年版)(下)[J].中国实用内科杂志,2021,41(9):668-695.
ZHU DL.Guidelines for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)(lower)[J].Chinese Journal of Practical Internal Medicine,2021,41(9):668-695.
[13] 中华医学会外科学分会外科感染与重症医学学组中国医师协会外科医师分会肠瘘外科医师专业委员会.中国腹腔感染诊治指南(2019版)[J].中国实用外科杂志,2020,40(1):1-16.
Surgical Infection and Critical Care Medicine Group of the Surgical Branch of the Chinese Medical Association Chinese Physicians Association of Surgeons Professional Committee of Intestinal Fistula Surgeons.Guidelines for diagnosis and treatment of abdominal infection in China (2019 edition)[J].Chinese Journal of Practical Surgery,2020,40(1):1-16.
[14] BENSON AB,VENOOK AP,AL-HAWARY MM,et al.Rectal cancer,version 2.2022,NCCN clinical practice guidelines in oncology[J].Natl Compr Canc Netw,2022,20(10):1139-1167.
[15] ZENG H,CHEN W,ZHENG R,et al.Changing cancer survival in China during 2003-15:a pooled analysis of 17 population-based cancer registries[J].The Lancet Global Health,2018,6(5):e555-e567.
[16] TOKUNAGA M,TANIZAWA Y,BANDO E,et al.Poor survival rate in patients with post-operative intra-abdominal infectious complications following curative gastrectomy for gastric cancer[J].Ann Surg Oncol,2013,20(5):1575-1583.
[17] REUDINK M,SLOOTER CD,JANSSEN L,et al.Metabolic syndrome;associations with adverse outcome after colorectal surgery.A systematic review and meta-analysis[J].Ann Med Surg (Lond),2021,71:102997.
[18] ZHU C,MAO C,CAI W,et al.The effect of metabolic syndrome on postoperative complications and long-term survival of patients with colorectal cancer[J].Front Oncol,2023,13:1036458.
[19] 叶国庆,许京轩,曾云鹏,等.联合肌肉减少症建立模型预测结直肠癌术后腹腔内感染风险[J].温州医科大学学报,2020,50(12):984-989.
YE GQ,XU JX,ZENG YP,et al.Modelling of combined sarcopenia to predict the risk of intra-abdominal infection after colorectal cancer surgery[J].Journal of Wenzhou Medical University,2020,50(12):984-989.
[20] SUEDA T,TEI M,YOSHIKAWA Y,et al.Prognostic impact of postoperative intra -abdominal infections after elective colorectal cancer resection on survival and local recurrence:a propensity score-matched analysis[J].Int J Colorectal Dis,2020,35(3):413-422.
[21] MODZELEWSKA P,CHLUDZINSKA S,LEWKO J,et al.The influence of leptin on the process of carcinogenesis[J].Contemp Oncol (Pozn),2019,23(2):63-68.
[22] 吴艳惠,杨鑫,吴现瑞.代谢综合征与结直肠癌相关性的研究进展[J].中国肿瘤外科杂志,2023,15(03):262-265.
WU YH,YANG X,WU XR.Research progress on the correlation between metabolic syndrome and colorectal cancer[J].Chinese Journal of Surgical Oncology,2023,15(03):262-265.
[23] UZUNLULU M,TELCI CAKALILI O,OGUZ A.Association between metabolic syndrome and cancer[J].Ann Nutr Metab,2016,68(3):173-179.
[24] 李昂,周毕军,陈中建,等.结直肠癌术后腹腔感染危险因素及与 UGT1A1*28位点基因多态性的关联[J].中华医院感染学杂志,2022,32(13):2015-2019.
LI A,ZHOU BJ,CHEN ZJ,et al.Risk factors for postoperative abdominal infection in colorectal cancer and association with gene polymorphisms at the UGT1A1*28 locus[J].Chinese Journal of Hospital Infection,2022,32(13):2015-2019.
[25] CHEN W,CHEN X,MA L,et al.Impact of visceral obesity and sarcopenia on short-term outcomes after colorectal cancer surgery[J].Digestive Dis Sci,2018,63(6):1620-1630.
[26] WANG HJ,XING XZ,QU SN,et al.A randomized controlled trial comparing the efficacy of tigecycline versus meropenem in the treatment of postoperative complicated intra-abdominal infections[J].Ann Palliat Med,2021,10(2):1262-1275.
[27] 程玉鹏,张颖艳,曹海珍.结直肠癌手术患者手术部位感染发生因素及预警模型的预测价值分析[J].消化肿瘤杂志(电子版),2022,14(04):455-460.
CHENG YP,ZHANG YY,CAO HZ.Analysis of factors of surgical site infection and predictive value of early warning model in patients undergoing colorectal cancer surgery[J].Journal of Digestive Oncology (Electronic Edition),2022,14(04):455-460.
[28] 孙广文,颜松龄,张国伟,等.腹腔镜下结直肠癌根治术的近期疗效及预后影响因素分析[J].癌症进展,2020,18(12):1267-1270.
SUN GW,YAN SL,ZHANG GW,et al.Efficacy and prognostic factors of laparoscopic radical surgery for colorectal cancer[J].Cancer Progress,2020,18(12):1267-1270.
[29] ROBERTS C,WON D,PRUTHI S,et al.Effect of a short-term diet and exercise intervention on oxidative stress,inflammation,MMP-9,and monocyte chemotactic activity in men with metabolic syndrome factors[J].J Appl Physiol,2006,100(5):1657-1665.
[30] 刘瑾,王玉华.短肽型肠内营养剂对结直肠癌围手术期患者的影响[J].中国药物经济学,2020,15(03):120-122,125.
LIU J,WANG YH.Effects of short peptide enteral nutrients on perioperative colorectal cancer patients[J].China Pharmacoeconomics,2020,15(03):120-122,125.